देश: यूनाइटेड किंगडम
भाषा: अंग्रेज़ी
स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)
Glimepiride
Brown & Burk UK Ltd
A10BB12
Glimepiride
4mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06010201; GTIN: 5060124640068
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER GLIMEPIRIDE 1 MG/2 MG/3 MG/4 MG TABLETS Glimepiride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illnesss are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Glimepiride is and what it is used for 2. What you need to know before you take Glimepiride 3. How to take Glimepiride 4. Possible side effects 5. How to store Glimepiride 6. Contents of the pack and other information 1. WHAT GLIMEPIRIDE IS AND WHAT IT IS USED FOR Glimepiride is one of a group of medicines called oral hypoglycaemics, which are used for treatment of diabetes (a disease where the body does not produce enough insulin to control the level of blood sugar). Oral hypoglycaemics help control blood sugar level. The active ingredient in your Glimepiride tablets is Glimepiride. WHAT GLIMEPIRIDE IS USED FOR: Glimepiride is used in the treatment of non-insulin dependent (Type II) diabetes mellitus. You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood. Type II diabetes can sometimes be controlled by good diet, physical exercise and weight reduction alone, but where this is not possible, Glimepiride is used in addition. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE GLIMEPIRIDE. DO NOT TAKE GLIMEPIRIDE: • if you are allergic to glimepiride or other sulfonylureas (medicines used to lower your blood sugar such as glibenclamide) or sulfonamides (medicines for bacterial infections such as sulfamethoxazole) or any of the other ingredients of this medicine (listed in section 6) • if you hav पूरा दस्तावेज़ पढ़ें
OBJECT 1 GLIMEPIRIDE 4 MG TABLETS Summary of Product Characteristics Updated 05-Jan-2021 | Brown & Burk UK Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Glimepiride 4 mg tablets 2. Qualitative and quantitative composition Glimepiride 4 mg tablets: 1 tablet contains Glimepiride 4 mg. Excipient with known effect Each tablet of Glimepiride 4 mg contains 140.00 mg of Lactose Monohydrate. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet Glimepiride 4mg is a Light blue coloured capsule shaped tablet with debossing “GM” & “4” with score line on one side and score line on the other side. The tablet can be divided into equal halves. 4. Clinical particulars 4.1 Therapeutic indications Glimepiride is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate. 4.2 Posology and method of administration Posology For oral administration The basis for successful treatment of पूरा दस्तावेज़ पढ़ें